FABP5 was first identified in psoriatic lesions, was linked to metastasis in 2000 where FABP5 mRNA was expressed in metastatic breast and prostate cancer cell lines compared to non-metastatic cell lines [9]. This evidence concerns the gene FABP5 and prostate carcinoma.